SD |
heart left ventricle weight to body weight ratio |
artificial aortocaval fistula (for 12 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle mass |
male |
0 days
| 6 |
g/g*103 |
2.3 |
mg/g |
0.1 |
0.24 |
post excision weight measurement |
1.0 |
ACF |
720 |
min |
98787 |
2160 |
SD |
heart left ventricle weight to body weight ratio |
artificial aortocaval fistula (for 2 days) then metoprolol succinate (100 mg/kg/d) (for 2 days) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle mass |
male |
0 days
| 6 |
g/g*103 |
2.8 |
mg/g |
0.1 |
0.24 |
post excision weight measurement |
1.0 |
ACF |
2 |
days |
98876 |
2160 |
SD |
heart left ventricle weight to body weight ratio |
sham surgical control condition (for 28 days) |
Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. |
heart left ventricle mass |
male |
77 days
| 6 |
|
1.56 |
mg/g |
0.03 |
0.07 |
ex vivo method |
0.0 |
sham lad occlusion |
28 |
days |
101096 |
2564 |
SD |
heart left ventricle weight to body weight ratio |
artificial aortocaval fistula (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle mass |
male |
175 days
| 10 |
|
3.1 |
mg/g |
0.1 |
0.32 |
post excision weight measurement |
0.0 |
ACF |
105 |
days |
99206 |
2278 |
SD |
heart left ventricle weight to body weight ratio |
sham surgical control condition (for 12 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle mass |
male |
0 days
| 6 |
g/g*103 |
2.3 |
mg/g |
0.1 |
0.24 |
post excision weight measurement |
1.0 |
sham ACF |
720 |
min |
98788 |
2160 |
SD |
heart left ventricle weight to body weight ratio |
sham surgical control condition (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle mass |
male |
98 days
| 8 |
|
2.1 |
mg/g |
0.1 |
0.28 |
post excision weight measurement |
0.0 |
sham ACF |
28 |
days |
99203 |
2278 |
SD |
heart left ventricle weight to body weight ratio |
sham surgical control condition (for 2 days) then vehicle control condition (for 2 days) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle mass |
male |
0 days
| 6 |
g/g*103 |
2.3 |
mg/g |
0.1 |
0.24 |
post excision weight measurement |
1.0 |
sham ACF |
2 |
days |
98875 |
2160 |
SD |
heart left ventricle weight to body weight ratio |
artificial aortocaval fistula (for 5 days) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle mass |
male |
0 days
| 6 |
g/g*103 |
2.7 |
mg/g |
0.1 |
0.24 |
post excision weight measurement |
1.0 |
ACF |
5 |
days |
98791 |
2160 |
SD |
heart left ventricle weight to body weight ratio |
sham surgical control condition (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle mass |
male |
175 days
| 10 |
|
1.9 |
mg/g |
0.1 |
0.32 |
post excision weight measurement |
0.0 |
sham ACF |
105 |
days |
99205 |
2278 |
SD |
heart left ventricle weight to body weight ratio |
sham surgical control condition (between 120 and 12 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle mass |
male |
0 days
| 6 |
g/g*103 |
2.3 |
mg/g |
0.1 |
0.24 |
post excision weight measurement |
1.0 |
sham ACF |
5 |
days |
98792 |
2160 |
SD |
heart left ventricle weight to body weight ratio |
artificial aortocaval fistula (for 2 days) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle mass |
male |
0 days
| 6 |
g/g*103 |
2.6 |
mg/g |
0.1 |
0.24 |
post excision weight measurement |
1.0 |
ACF |
2 |
days |
98789 |
2160 |
SD |
heart left ventricle weight to body weight ratio |
left anterior descending coronary artery occlusion (for 28 days) |
Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. |
heart left ventricle mass |
male |
77 days
| 6 |
|
1.67 |
mg/g |
0.04 |
0.1 |
ex vivo method |
0.0 |
lad occlusion |
28 |
days |
101095 |
2564 |
SD |
heart left ventricle weight to body weight ratio |
left anterior descending coronary artery occlusion (for 140 days) |
Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. |
heart left ventricle mass |
male |
189 days
| 10 |
|
1.53 |
mg/g |
0.04 |
0.13 |
ex vivo method |
0.0 |
lad occlusion |
140 |
days |
101097 |
2564 |
SD |
heart left ventricle weight to body weight ratio |
sham surgical control condition (for 140 days) |
Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. |
heart left ventricle mass |
male |
189 days
| 6 |
|
1.44 |
mg/g |
0.02 |
0.05 |
ex vivo method |
0.0 |
sham lad occlusion |
140 |
days |
101098 |
2564 |
SD |
heart left ventricle weight to body weight ratio |
artificial aortocaval fistula (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle mass |
male |
98 days
| 8 |
|
3.1 |
mg/g |
0.1 |
0.28 |
post excision weight measurement |
0.0 |
ACF |
28 |
days |
99204 |
2278 |
SD |
heart left ventricle weight to body weight ratio |
sham surgical control condition (for 2 days) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle mass |
male |
0 days
| 6 |
g/g*103 |
2.2 |
mg/g |
0.1 |
0.24 |
post excision weight measurement |
1.0 |
sham ACF |
2 |
days |
98790 |
2160 |
SD |
heart left ventricle weight to body weight ratio |
sham surgical control condition (for 6 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle mass |
male |
0 days
| 6 |
g/g*103 |
2.2 |
mg/g |
0.1 |
0.24 |
post excision weight measurement |
1.0 |
sham ACF |
360 |
min |
98786 |
2160 |
SD |
heart left ventricle weight to body weight ratio |
artificial aortocaval fistula (for 2 days) then vehicle control condition (for 2 days) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle mass |
male |
0 days
| 6 |
g/g*103 |
2.6 |
mg/g |
0.1 |
0.24 |
post excision weight measurement |
1.0 |
ACF |
2 |
days |
98874 |
2160 |
SD |
heart left ventricle weight to body weight ratio |
artificial aortocaval fistula (for 6 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle mass |
male |
0 days
| 6 |
g/g*103 |
2.2 |
mg/g |
0.1 |
0.24 |
post excision weight measurement |
1.0 |
ACF |
360 |
min |
98785 |
2160 |
SD |
heart left ventricle weight to body weight ratio |
sham surgical control condition (for 2 days) then metoprolol succinate (100 mg/kg/d) (for 2 days) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle mass |
male |
0 days
| 6 |
g/g*103 |
2.5 |
mg/g |
0.1 |
0.24 |
post excision weight measurement |
1.0 |
sham ACF |
2 |
days |
98877 |
2160 |